Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 4,946,443 7.100% | 1,649,663![]() (+50.04%) | Filing History |
| 2022-09-06 4:30 pm Purchase | 2022-08-24 | 13G | COGENT BIOSCIENCES INC COGT | RA CAPITAL MANAGEMENT L.P. | 3,612,207 5.490% | 3,612,207![]() (New Position) | Filing History |
| 2022-07-08 4:57 pm Purchase | 2022-06-30 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 3,296,780 3.800% | 598,126![]() (+22.16%) | Filing History |
| 2022-06-21 10:04 am Purchase | 2022-06-16 | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 15,230,473 19.990% | 7,748,013![]() (+103.55%) | Filing History |
| 2022-06-17 08:00 am Purchase | 2022-06-13 | 13G | COGENT BIOSCIENCES INC COGT | Flynn James E | 5,876,805 9.640% | 5,876,805![]() (New Position) | Filing History |
| 2022-03-01 2:40 pm Purchase | 2022-02-24 | 13G | COGENT BIOSCIENCES INC COGT | Frazier Life Sciences Public Fund, L.P. | 2,188,004 11.000% | 2,188,004![]() (New Position) | Filing History |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Venrock Healthcare Capital Partners II, L.P. | 4,302,126 9.990% | -53,147![]() (-1.22%) | Filing History |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Ridgeback Capital Investments L.P. | 0 0.000% | -1,252,250![]() (Position Closed) | Filing History |
| 2022-02-14 4:07 pm Purchase | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,281,315 5.700% | 139,976![]() (+6.54%) | Filing History |
| 2022-02-14 2:05 pm Sale | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Logos Global Management LP | 150,000 0.400% | -1,757,971![]() (-92.14%) | Filing History |
| 2022-02-14 1:38 pm Purchase | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BIOTECHNOLOGY VALUE FUND L P | 3,114,532 7.500% | 282![]() (+0.01%) | Filing History |
| 2022-02-14 11:33 am Purchase | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Eventide Asset Management, LLC | 3,514,909 8.800% | 3,514,909![]() (New Position) | Filing History |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Ally Bridge MedAlpha Master Fund L.P. | 1,501,591 3.800% | -121,000![]() (-7.46%) | Filing History |
| 2022-02-11 1:34 pm Purchase | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | JANUS HENDERSON GROUP PLC JHG | 2,515,254 6.300% | 2,515,254![]() (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 2,698,654 6.800% | 1,204,551![]() (+80.62%) | Filing History |
| 2022-01-25 11:32 am Unchanged | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Atlas Venture Fund IX L.P. | 916,196 2.300% | 0 (Unchanged) | Filing History |
| 2021-11-17 3:39 pm Purchase | 2021-11-05 | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover Management LLC | 2,716,042 6.800% | 706,054![]() (+35.13%) | Filing History |
| 2021-11-03 5:31 pm Purchase | 2021-10-07 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,141,339 5.400% | 2,141,339![]() (New Position) | Filing History |
| 2021-07-08 1:50 pm Purchase | 2021-06-28 | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover Management LLC | 2,009,988 5.200% | 2,009,988![]() (New Position) | Filing History |

